American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
66 hedge funds and large institutions have $262M invested in American Oncology Network, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 8 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
8% more funds holding
Funds holding: 61 → 66 (+5)
6% more capital invested
Capital invested by funds: $246M → $262M (+$15.2M)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$2.44M |
| 2 |
KLM
Kennedy Lewis Management
New York
|
-$1.95M |
| 3 |
DCP
Diameter Capital Partners
New York
|
-$1.46M |
| 4 |
AC
Athanor Capital
New York
|
-$1.2M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$975K |
AONC Hedge Fund Activity: Q1 2022 in Review
66 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q1 2022, worth a combined $262M — up 6.2% from $246M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AONC positions and 8 closed out — a net gain of 5 holders — while 17 added to existing stakes and 6 trimmed.
The largest buyer was Alberta Investment Management Corp (AIMCo), opening a new position worth an estimated $3.4M. The largest seller was Blackstone Inc, exiting entirely with an estimated $2.44M sold.
- 66 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q1 2022, up from 61 in Q4 2021.
- Funds reported $262M of American Oncology Network, Inc. Class A Common Stock stock for Q1 2022, up 6.2% quarter-over-quarter.
- 13 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q1 2022 and 8 closed out, a net change of +5 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q1 2022 was Alberta Investment Management Corp (AIMCo), an estimated $3.4M added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q1 2022 was Blackstone Inc, an estimated $2.44M sold.
Based on aggregated 13F filings for Q1 2022.